Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma.

Front Med (Lausanne) · 2021 · PMC8606547 · PMID 34820398

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nearly significantno p-value reported

In contrast to the increased co-expression of TIGIT and CD39 in all γδ T cells in AML and MM, the clustering of CD39 on Vδ1 in comparison to the corresponding Vδ2 γδ T cell subset was only nearly significant in MM, and not significant in AML.

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.